No Data
Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Top Holders Are Insiders and They Are Likely Disappointed by the Recent 6.4% Drop
Shenzhen YHLO Biotech Elects Chair, Vice Chair
Yahuilong (688575.SH): Hu Kunhui has been elected as Director.
Gelonghui, December 16丨Yahui Long (688575.SH) announced that the members of the fourth Board of Directors have been elected at the first extraordinary Shareholder meeting of the company in 2024. Mr. Hu Kunhui was elected as the chairman of the company's fourth Board of Directors, with a term beginning from the date of approval by this Board of Directors until the end of the term of the fourth Board of Directors.
Shenzhen YHLO Biotech Gets Medical Device Registrations From Hunan Administrator
Yahui Long (688575.SH): Subsidiary obtains medical instruments registration certificate
Gelonghui November 27th | Yahui Long (688575.SH) announced that its wholly-owned subsidiary, Hunan Yahui Long Biotechnology Co., Ltd., has received a medical device registration certificate issued by the Hunan Provincial Food and Drug Administration. As of now, the company has successively obtained 161 domestic medical device registration certificates for chemiluminescent reagents (out of a total of 231 domestic registration certificates for chemiluminescent reagents). The acquisition of this reagent project registration certificate is conducive to further enriching the company's fully automated chemiluminescent product line, improving Yahui Long's own autoimmune disease testing packages. As of now, the company has successively obtained 57 chemiluminescent self-exemption test registrations.
Shenzhen YHLO Biotech (SHSE:688575) Could Be Struggling To Allocate Capital
Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Popularity With Investors Is Under Threat From Overpricing
